1FQ3
CRYSTAL STRUCTURE OF HUMAN GRANZYME B
1FQ3 の概要
| エントリーDOI | 10.2210/pdb1fq3/pdb |
| 分子名称 | GRANZYME B, beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose, SULFATE ION (3 entities in total) |
| 機能のキーワード | chymotrypsin-like serine proteinase, hydrolase |
| 由来する生物種 | Homo sapiens (human) |
| 細胞内の位置 | Cytoplasmic granule: P10144 |
| タンパク質・核酸の鎖数 | 2 |
| 化学式量合計 | 52472.29 |
| 構造登録者 | Estebanez-Perpina, E.,Fuentes-Prior, P.,Belorgey, D.,Rubin, H.,Bode, W. (登録日: 2000-09-03, 公開日: 2001-01-31, 最終更新日: 2024-10-16) |
| 主引用文献 | Estebanez-Perpina, E.,Fuentes-Prior, P.,Belorgey, D.,Braun, M.,Kiefersauer, R.,Maskos, K.,Huber, R.,Rubin, H.,Bode, W. Crystal structure of the caspase activator human granzyme B, a proteinase highly specific for an Asp-P1 residue. Biol.Chem., 381:1203-1214, 2000 Cited by PubMed Abstract: Granzyme B is the prototypic member of the granzymes, a family of trypsin-like serine proteinases localized in the dense cytoplasmic granules of activated natural killer cells and cytotoxic T lymphocytes. Granzyme B directly triggers apoptosis in target cells by activating the caspase pathway, and has been implicated in the etiology of rheumatoid arthritis. Human granzyme B expressed in a baculovirus system has been crystallized without inhibitor and its structure has been determined to 3.1 A resolution, after considerably improving the diffraction power of the crystals by controlled humidity changes. The granzyme B structure reveals an overall fold similar to that found in cathepsin G and human chymase. The guanidinium group of Arg226, anchored at the back of the S1-specificity pocket, can form a salt bridge with the P1-Asp side chain of a bound peptide substrate. The architecture of the substrate binding site of granzyme B appears to be designed to accommodate and cleave hexapeptides such as the sequence Ile-Glu-Thr-Asp-/Ser-Gly present in the activation site of pro-caspase-3, a proven physiological substrate of granzyme B. These granzyme B crystals, with fully accessible active sites, are well suited for soaking with small synthetic inhibitors that might be used for a treatment of chronic inflammatory disorders. PubMed: 11209755DOI: 10.1515/BC.2000.148 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (3.1 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






